Cargando…
Effect of Cannabidiol on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells
Cannabidiol (CBD), the main non-psychoactive component of Cannabis sativa L., is widely used in therapy for the treatment of different diseases and as an adjuvant drug. Our aim was to assess the effects of CBD on proinflammatory cytokine production and cell proliferation in human peripheral blood mo...
Autores principales: | Furgiuele, Alessia, Marino, Franca, Rasini, Emanuela, Legnaro, Massimiliano, Luini, Alessandra, Albizzati, Maria Giulia, di Flora, Alessia, Pacchetti, Barbara, Cosentino, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573927/ https://www.ncbi.nlm.nih.gov/pubmed/37834328 http://dx.doi.org/10.3390/ijms241914880 |
Ejemplares similares
-
A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions
por: Mabou Tagne, Alex, et al.
Publicado: (2019) -
Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review
por: Furgiuele, Alessia, et al.
Publicado: (2021) -
Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease
por: Kustrimovic, Natasa, et al.
Publicado: (2016) -
Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients
por: Kustrimovic, Natasa, et al.
Publicado: (2018) -
Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?
por: Furgiuele, Alessia, et al.
Publicado: (2023)